Retatrutide, semaglutide, tirzepatide, dulaglutide, liraglutide, exenatide, and all other GLP-1 receptor agonists are not on any panel
Patients consistently reported enhanced daily functioning, improved quality of life, and better management of conditions like hypertension and diabetes
Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Sterile water lacks this preservative, increasing the risk of contamination with each use